M. Namba

M. Namba, J. Miyagawa, T. Katsuno, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes.

H. Watada, T. Kitamura, Masaki Kobayashi, 2020, Endocrine journal.

Demonstration of Two Different Processes of β-Cell Regeneration in a New Diabetic Mouse Model Induced by Selective Perfusion of Alloxan

Y. Matsuzawa, Y. Yamasaki, A. Imagawa, 1997, Diabetes.

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

Partial HPRT Deficiency with a Novel Mutation of the HPRT Gene in Combination with Four Previously Reported Variants Associated with Hyperuricemia.

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2015, Internal medicine.

Risk factors for the progression of microalbuminuria in Japanese type 2 diabetic patients--a 10 year follow-up study.

Y. Matsuzawa, T. Hanafusa, M. Namba, 1999, Diabetes research and clinical practice.

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

T. Sanke, M. Noda, T. Hanafusa, 2012, Diabetology International.

Hepatocyte nuclear factor-4 alpha gene mutations in Japanese non-insulin dependent diabetes mellitus (NIDDM) patients.

Y. Matsuzawa, R. Shingu, T. Hanafusa, 1996, Research communications in molecular pathology and pharmacology.

Plasma brain-derived neurotrophic factor concentration is a predictor of chronic kidney disease in patients with cardiovascular risk factors – Hyogo Sleep Cardio-Autonomic Atherosclerosis study

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017 .

Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alpha.

Y. Matsuzawa, K. Fukui, K. Yamagata, 2002, Diabetes.

Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide.

M. Namba, T. Hirose, T. Hamaguchi, 2004, Diabetes research and clinical practice.

The current status of treatment‐related severe hypoglycemia in Japanese patients with diabetes mellitus: A report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society

M. Matsuhisa, K. Akazawa, T. Yamauchi, 2018, Journal of diabetes investigation.

New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy

M. Namba, J. Miyagawa, T. Katsuno, 2013, Clinical and Experimental Nephrology.

Various phenotypes of diabetes mellitus at ultimate outcome of acutely developed diabetic state induced by viral infection.

M. Namba, S. Tarui, K. Nonaka, 1982, Endocrinologia japonica.

Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus

Y. Matsuzawa, S. Nagata, K. Yamagata, 1999, Diabetologia.

Metabolic consequence of long-term exposure of pancreatic beta cells to free fatty acid with special reference to glucose insensitivity.

J. Miyazaki, Y. Matsuzawa, T. Hanafusa, 2002, Biochimica et biophysica acta.

Altered expression of carnitine palmitoyltransferase II in liver, muscle, and heart of mouse strain with juvenile visceral steatosis.

Y. Matsuzawa, T. Saheki, K. Hotta, 1996, Biochimica et biophysica acta.

Disordered expression of glycolytic and gluconeogenic liver enzymes of juvenile visceral steatosis mice with systemic carnitine deficiency.

Y. Matsuzawa, T. Saheki, T. Noguchi, 1996, Diabetes research and clinical practice.

Disordered expression of hepatic glycolytic and gluconeogenic enzymes in Otsuka Long-Evans Tokushima fatty rats with spontanteous long-term hyperglycemia.

Y. Matsuzawa, R. Shingu, T. Noguchi, 1996, Biochimica et biophysica acta.

Neogenesis and proliferation of beta-cells induced by human betacellulin gene transduction via retrograde pancreatic duct injection of an adenovirus vector.

I. Shimomura, K. Yamagata, M. Namba, 2006, Biochemical and biophysical research communications.

Proliferation and differentiation of pancreatic β-cells: ultrastructural analysis of the pancreas in diabetic mice induced by selective alloxan perfusion

Y. Matsuzawa, A. Imagawa, T. Hanafusa, 1997, Medical Electron Microscopy.

Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells.

Y. Matsuzawa, K. Yamagata, T. Hanafusa, 1999, Endocrine journal.

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Therapeutics and clinical risk management.

Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2011, Endocrine journal.

Islet-infiltrating t lymphocytes in insulin-dependent diabetic patients express CD80 (B7-1) and CD86 (B7-2).

D. Harlan, Y. Matsuzawa, A. Imagawa, 1996, Journal of autoimmunity.

Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017, American journal of lifestyle medicine.

Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion.

Y. Matsuzawa, K. Yamagata, A. Imagawa, 2000, Diabetes.

Emerging therapeutic strategies in autoimmune diabetes: aetiology, prediction, prevention and cure

Y. Matsuzawa, K. Yamagata, A. Imagawa, 1999 .

Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic beta-cell line.

J. Miyazaki, Y. Matsuzawa, T. Hanafusa, 2000, The Journal of endocrinology.

Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2

Y. Matsuzawa, T. Noguchi, Y. Tsujimoto, 1996, Diabetologia.

Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Journal of diabetes investigation.

Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus.

Y. Matsuzawa, T. Noguchi, K. Yamagata, 1996, Diabetes research and clinical practice.

Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus.

M. Namba, J. Miyagawa, H. Ikeda, 2013, Endocrine journal.

Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance.

M. Namba, J. Miyagawa, T. Katsuno, 2014, Diabetes research and clinical practice.

Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor.

Y. Matsuzawa, N. Iwasaki, K. Yamagata, 1999, Biochemical and biophysical research communications.

Effects of glucagon on urinary excretion of urea and on plasma ammonia level in argininosuccinate synthetase deficiency

Y. Matsuzawa, M. Namba, S. Kawata, 2005, Journal of Gastroenterology.

Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients.

Y. Matsuzawa, R. Shingu, T. Hanafusa, 1998, The Journal of clinical endocrinology and metabolism.

Responses of catecholamines and other counterregulatory hormones to insulin-induced hypoglycemia in totally pancreatectomized patients.

M. Namba, H. Horie, H. Wada, 1984, The Journal of clinical endocrinology and metabolism.

Modulation by prostaglandin D2 of glucagon and insulin secretion in the perfused rat pancreas.

M. Namba, H. Horie, S. Tarui, 1983, Prostaglandins, leukotrienes, and medicine.

Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes.

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Endocrine journal.

Inhibition of pancreatic exocrine secretion and augmentation of the release of gut glucagon-like immunoreactive materials by intraileal administration of bile in the dog

M. Namba, H. Horie, S. Tarui, 1983, Regulatory Peptides.

Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.

Y. Matsuzawa, T. Hanafusa, M. Namba, 1996, Biochimica et biophysica acta.

Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.

M. Namba, S. Tarui, K. Nonaka, 1980, Endocrinologia japonica.

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

Y. Matsuzawa, S. Nagata, A. Imagawa, 1997, The Journal of experimental medicine.

The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: a report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society

M. Matsuhisa, K. Akazawa, T. Yamauchi, 2018, Diabetology International.

Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data

M. Namba, J. Miyagawa, T. Katsuno, 2014, Drugs in R&D.

Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes

H. Koyama, M. Namba, T. Murase, 2019, Acta Diabetologica.

EFFECT OF NEUROMEDIN B ON GUT HORMONE SECRETION IN THE RAT

T. Adrian, S. Bloom, M. Namba, 1984 .

Distribution and chromatographic characterization of neuromedin B-like immunoreactivity in the human spinal cord

P. Anand, S. Bloom, M. Namba, 1985, Brain Research.

Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017, Metabolism: clinical and experimental.

Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β

Y. Matsuzawa, C. Wollheim, K. Yamagata, 1999 .

[Incretin-based therapy in patients with type 1 diabetes mellitus].

M. Namba, J. Miyagawa, M. Miuchi, 2011, Nihon rinsho. Japanese journal of clinical medicine.

Incretin responses to oral glucose load in Japanese non-obese healthy subjects

M. Namba, T. Hamaguchi, J. Miyagawa, 2011, Diabetes therapy : research, treatment and education of diabetes and related disorders.

EXAGGERATED INSULIN SECRETORY RESPONSE IN PATIENTS WITH INSULINOMAS TO MIDAGLIZOLE, A DRUG WITH α2‐ADRENERGIC BLOCKING ACTIVITY

T. Hanafusa, H. Kiyokawa, M. Namba, 1988, Clinical endocrinology.

Accelerated decline of blood glucose after intravenous glucose injection in a patient with Cowden disease having a heterozygous germline mutation of the PTEN/MMAC1 gene.

Y. Matsuzawa, T. Hanafusa, M. Namba, 2000, Anticancer research.

Presence of neuromedin B-like immunoreactivity in the brain and gut of rat and guinea-pig

S. Bloom, M. Namba, M. Ghatei, 1985, Peptides.

Distribution and localization of neuromedin B-like immunoreactivity in pig, cat and rat spinal cord

J. Polak, S. Bloom, M. Namba, 1985, Neuroscience.

Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Drugs in R&D.

Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2)

I. Shimomura, K. Fukui, J. Terasaki, 2021, Advances in Therapy.

Safety of the batteries and power units used in insulin pumps: A pilot cross‐sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan

M. Matsuhisa, N. Sakane, A. Kuroda, 2017, Journal of diabetes investigation.

Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.

Y. Shinomura, M. Namba, S. Tarui, 1989, Biochemical and biophysical research communications.

Glucagonlike peptide-1(7-36)amide suppresses glucagon secretion and decreases cyclic AMP concentration in cultured In-R1-G9 cells.

Y. Matsuzawa, M. Namba, M. Tanaka, 1992, Biochemical and biophysical research communications.

The role of prohormone convertases PC1 (PC3) and PC2 in the cell-specific processing of proglucagon.

Y. Matsuzawa, R. Shingu, M. Namba, 1995, Biochemical and biophysical research communications.

A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine

M. Namba, J. Miyagawa, T. Katsuno, 2016, Acta Diabetologica.

Inhibition of pentagastrin-stimulated gastric acid secretion by intraileal administration of bile and elevation of plasma concentrations of gut glucagon-like immunoreactivity in anesthetized dogs

M. Namba, H. Horie, S. Tarui, 1986, Regulatory Peptides.

Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7–36)-Amide

M. Namba, S. Tarui, N. Kono, 1989, Diabetes.

MULTIPLE FORMS OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON-LIKE IMMUNOREACTIVITIES IN CANINE GASTROINTESTINAL TRACT AND THEIR RELEASE INTO CIRCULATION

M. Namba, S. Tarui, N. Kono, 1990 .

Trophic effect of glucagon-(1-21)-peptide on the isolated rat ileal mucosal cells.

M. Namba, S. Tarui, N. Kono, 1988, Biochemical and biophysical research communications.

DIFFERENTIATION OF B—CELLS FROM DUCTAL CELLS AND ACCELERATION OF THIS PROCESS BY NICOTINAMIDE: ULTRASTRUCTURAL STUDY ON THE NON-OBESE DIABETIC (NOD) MICE WITH OVERT DIABETES

Y. Matsuzawa, T. Hanafusa, M. Namba, 1997 .

Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy.

T. Hanafusa, M. Namba, H. Horie, 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Prevalence of diabetic retinopathy and distribution of its severity among patients of a university clinic of diabetes in Osaka.

M. Namba, H. Horie, I. Mineo, 1983, The Tohoku journal of experimental medicine.

Expression and distribution of glucose-6-phosphatase catalytic subunit messenger RNA and its changes in the diabetic state.

Y. Matsuzawa, R. Shingu, T. Hanafusa, 1996, Research communications in molecular pathology and pharmacology.

Glucose dependent stimulation by prostaglandin D2 of glucagon and insulin in perfused rat pancreas.

M. Namba, H. Horie, S. Tarui, 1983, Life sciences.

Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2016, Internal medicine.

Dominant TCR α-chain clonotypes and interferon-γ are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus

Y. Matsuzawa, T. Noguchi, K. Yamagata, 1996 .

Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization

Y. Matsuzawa, K. Yamagata, A. Imagawa, 1999, Diabetologia.

Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, World journal of diabetes.

First International Cisapride Investigators’ Meeting

W. Schwerk, K. Ohlsson, J. Iovanna, 1986 .

Effects of decapeptide of mammalian bombesin and neuromedin B on pancreatic exocrine secretion in the rat.

S. Bloom, M. Namba, M. Ghatei, 1986, Digestion.

Effect of glucagon-(1-21)-peptide on secretin-stimulated pancreatic exocrine secretion in anesthetized dogs.

M. Namba, S. Tarui, N. Kono, 1989, Life sciences.

Mutation P291fsinsC in the Transcription Factor Hepatocyte Nuclear Factor-1α is Dominant Negative

J. Miyazaki, T. Noguchi, K. Yamagata, 1998, Diabetes.

Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin.

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Endocrine journal.

Anaplastic thyroid carcinoma accompanied by uncontrollable eosinophilia.

S. Hirota, Y. Moriwaki, Tetsuya Yamamoto, 2015, Internal medicine.

Serum Macro TSH Level is Associated with Sleep Quality in Patients with Cardiovascular Risks – HSCAA Study

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017, Scientific Reports.

UNALTERED STIMULATION OF PITUITARY ADRENOCORTICOTROPHIN SECRETION BY CORTICOTROPHIN‐RELEASING FACTOR FOLLOWING SODIUM VALPROATE ADMINISTRATION IN A PATIENT WITH NELSON'S SYNDROME

M. Namba, S. Tarui, M. Gomi, 1985, Clinical endocrinology.

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2010, Metabolism: clinical and experimental.

High frequency of tetraploidy detected in malignant melanoma of Japanese patients by fluorescence in situ hybridization.

Y. Kitano, K. Mihara, M. Namba, 2000, International journal of oncology.

Evaluation of a Minimally Invasive System for Measuring Glucose Area under the Curve during Oral Glucose Tolerance Tests: Usefulness of Sweat Monitoring for Precise Measurement

Hiromu Nakajima, Wataru Ogawa, Hiroshi Maegawa, 2013, Journal of diabetes science and technology.

INHIBITORY EFFECT OF NEUROMEDIN B ON THE RELEASE OF THYROTROPIN FROM PERIFUSED RAT PITUITARIES

M. Namba, S. Tarui, K. Tajima, 1989 .

Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity.

Y. Matsuzawa, K. Yamagata, A. Imagawa, 2001, Diabetes.

Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

H. Koyama, M. Namba, T. Katsuno, 2020, Journal of diabetes investigation.

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Diabetes Therapy.

Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks

H. Saito, M. Namba, S. Kurebayashi, 2011, Journal of diabetes investigation.

Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2016, PloS one.

Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2015, Cardiovascular Diabetology.

Proceedings of the 25th annual meeting From October 13–15, 1983—Yamaguchi, Japan

T. Kanno, H. Tajiri, S. Yoshida, 1984, Gastroenterologia Japonica.

Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks

T. Kadowaki, M. Namba, A. Yamamura, 2010, Journal of diabetes investigation.

Plasma leptin concentration is associated with fatigue severity in patients with cardiovascular risk factors – HSCAA study

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2016, Psychoneuroendocrinology.

Plasma Brain-Derived Neurotrophic Factor and Reverse Dipping Pattern of Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2014, PloS one.

Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2015, World journal of experimental medicine.

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay

M. Namba, J. Miyagawa, T. Katsuno, 2015, Journal of diabetes investigation.

Thyroid Hormone Receptor Interacting Protein 3 (Trip3) Is a Novel Coactivator of Hepatocyte Nuclear

Y. Matsuzawa, Q. Zhu, K. Fukui, 2002 .

Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

M. Namba, J. Miyagawa, T. Katsuno, 2015, Diabetes research and clinical practice.

Thyroid Hormone Receptor Interacting Protein 3 (Trip3) Is a Novel Coactivator of Hepatocyte Nuclear Factor-4α

Y. Matsuzawa, Q. Zhu, K. Fukui, 2002 .

Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse.

Y. Matsuzawa, T. Hanafusa, M. Namba, 1996, Biochemical and Biophysical Research Communications - BBRC.

The PREDICTIVETM Study: a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes—data from the Japan cohort

Yuichiro Yamada, Kohei Kaku, Kohjiro Ueki, 2012, Diabetology International.

Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.

M. Namba, S. Tarui, T. Matsuyama, 1988, Diabetes research and clinical practice.

Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.

Y. Matsuzawa, C. Wollheim, K. Yamagata, 1999, Biochemical and biophysical research communications.

Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.

Y. Matsuzawa, K. Hotta, T. Hanafusa, 1998, Journal of molecular and cellular cardiology.

[Homeostasis model assessment as a clinical index of insulin resistance].

M. Namba, T. Hamaguchi, J. Miyagawa, 2006, Nihon rinsho. Japanese journal of clinical medicine.

Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes

M. Namba, T. Hamaguchi, T. Katsuno, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Continuous stimulation of human glucagon-like peptide-1 (7–36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes

I. Shimomura, K. Yamagata, M. Namba, 2007, Diabetologia.

Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges

Manabu Kadoya, Akinori Kanzaki, M. Namba, 2023, Journal of Diabetes Investigation.

the Role of Real time-Continuous the Role of Real time-Continuous Glucose monitoring in type 1 Glucose monitoring in type 1 Diabetes Patients with Recurrent Diabetes Patients with Recurrent severe Hypoglycaemia severe Hypoglycaemia

M. Namba, F. Cameron, D. Selam, 2010 .

Acute Effects of Oral Tofisopam on Plasma Concentration and Urinary Excretion of Uric Acid and Oxypurinol "Preliminary Communication".

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2015, Current clinical pharmacology.

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

M. Namba, T. Hamaguchi, J. Miyagawa, 2014 .

Decreased Response of Epinephrine and Norepinephrine to Insulin-Induced Hypoglycemia in Diabetic Autonomic Neuropathy

T. Hanafusa, M. Namba, H. Horie, 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Plasma brain-derived neurotrophic factor concentration is a predictor of chronic kidney disease in patients with cardiovascular risk factors – Hyogo Sleep Cardio-Autonomic Atherosclerosis study

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017, PloS one.

Partial HPRT Deficiency with a Novel Mutation of the HPRT Gene in Combination with Four Previously Reported Variants Associated with Hyperuricemia.

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2015, Internal medicine.